Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBL-024 Combination Therapy in Metastatic Colorectal Carcinoma
NCT07791758Phase 2Recruiting
- Sponsor
- Leads Biolabs
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
A Phase 2 trial of opamtistomig in colorectal cancer (CRC), sponsored by Leads Biolabs. Started Sep 2026; status: recruiting.
02
Drugs
opamtistomig
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07791758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07791758.